Work

Erlotinib/gemcitabine for first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas.

Year: 2007

Type: article

Source: PubMed

Authors: Adrian M Senderowicz, John R Johnson, Rajeshwari Sridhara, Paul Zimmerman, Robert Justice, Richard Pazdur

Institutions: United States Food and Drug Administration, Center for Drug Evaluation and Research

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W197533601

FWCI: 3.045

Cites: 10

Cited by: 65

Related to: 10